However, there were no significant associations between eIF4E expression and other important clinicopathological features, such as histological type, lymph node metastasis, and clinical staging in NSCLC patients (all P > 0.05, Table 2). The gene discussed is EIF4E; the disease is metastatic malignant neoplasm in the lymph nodes.